Patents Assigned to Suzhou Smartnuclide Biopharmaceutical Co., Ltd.
  • Publication number: 20210253709
    Abstract: The invention relates to the field of biomedicine. Specifically, the invention relates to a specific PD-L1 binding polypeptide and uses thereof in particular, uses m detecting and/or diagnosing PD-L1 related diseases such as cancers.
    Type: Application
    Filed: December 29, 2020
    Publication date: August 19, 2021
    Applicant: Suzhou Smartnuclide Biopharmaceutical Co., Ltd.
    Inventors: Tao Xu, Yan Sun, Hao Qi, Haijing Du, Tingting Hu, Yanling Yang, Fangfang Li, Qi Zhao, Songbing Qin